<SEC-DOCUMENT>0000921895-25-001089.txt : 20250415
<SEC-HEADER>0000921895-25-001089.hdr.sgml : 20250415
<ACCEPTANCE-DATETIME>20250415182255
ACCESSION NUMBER:		0000921895-25-001089
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20250415
DATE AS OF CHANGE:		20250415

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Green Plains Inc.
		CENTRAL INDEX KEY:			0001309402
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				841652107
		STATE OF INCORPORATION:			IA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-81560
		FILM NUMBER:		25840839

	BUSINESS ADDRESS:	
		STREET 1:		1811 AKSARBEN DRIVE
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68106
		BUSINESS PHONE:		402-884-8700

	MAIL ADDRESS:	
		STREET 1:		1811 AKSARBEN DRIVE
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Green Plains Renewable Energy, Inc.
		DATE OF NAME CHANGE:	20100106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GREEN PLAINS RENEWABLE ENERGY, INC.
		DATE OF NAME CHANGE:	20060314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Green Plains Renewable Energy, Inc.
		DATE OF NAME CHANGE:	20041123

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ancora Alternatives LLC
		CENTRAL INDEX KEY:			0001836192
		ORGANIZATION NAME:           	
		EIN:				854053337
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		6060 PARKLAND BLVD.
		STREET 2:		SUITE #200
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44124
		BUSINESS PHONE:		216-825-4000

	MAIL ADDRESS:	
		STREET 1:		6060 PARKLAND BLVD.
		STREET 2:		SUITE #200
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44124
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Ancora Alternatives LLC -->
          <cik>0001836192</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>04/11/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001309402</issuerCIK>
        <issuerCUSIP>393222104</issuerCUSIP>
        <issuerName>Green Plains Inc.</issuerName>
        <address>
          <com:street1>1811 AKSARBEN DRIVE</com:street1>
          <com:city>OMAHA</com:city>
          <com:stateOrCountry>NE</com:stateOrCountry>
          <com:zipCode>68106</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>FREDRICK DISANTO</personName>
          <personPhoneNum>216-825-4000</personPhoneNum>
          <personAddress>
            <com:street1>C/O ANCORA HOLDINGS GROUP, LLC</com:street1>
            <com:street2>6060 Parkland Boulevard, Suite 200</com:street2>
            <com:city>Cleveland</com:city>
            <com:stateOrCountry>OH</com:stateOrCountry>
            <com:zipCode>44124</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>ANDREW FREEDMAN</personName>
          <personPhoneNum>212-451-2300</personPhoneNum>
          <personAddress>
            <com:street1>OLSHAN FROME WOLOSKY LLP</com:street1>
            <com:street2>1325 Avenue of the Americas</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10019</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001836192</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Alternatives LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>OH</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4329900.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4329900.00</sharedDispositivePower>
        <aggregateAmountOwned>4329900.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.7</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001694450</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Merlin, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>33024.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>33024.00</sharedDispositivePower>
        <aggregateAmountOwned>33024.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001431892</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>ANCORA MERLIN INSTITUTIONAL, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>575965.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>575965.00</sharedDispositivePower>
        <aggregateAmountOwned>575965.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001694346</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Catalyst, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>46744.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>46744.00</sharedDispositivePower>
        <aggregateAmountOwned>46744.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001620142</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Catalyst Institutional, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>568378.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>568378.00</sharedDispositivePower>
        <aggregateAmountOwned>568378.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001991780</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Bellator Fund, LP</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>364641.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>364641.00</sharedDispositivePower>
        <aggregateAmountOwned>364641.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001873269</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Impact Fund LP - Series Q</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>400904.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>400904.00</sharedDispositivePower>
        <aggregateAmountOwned>400904.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>This Series Q is part of a series of Ancora Impact Fund LP, a series limited partnership.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001873416</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Impact Fund LP - Series S</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>822563.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>822563.00</sharedDispositivePower>
        <aggregateAmountOwned>822563.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>1.3</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>This Series S is part of a series of Ancora Impact Fund LP, a series limited partnership.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001873427</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Ancora Impact Fund SPC Ltd. - Segregated Portfolio H</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1021660.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1021660.00</sharedDispositivePower>
        <aggregateAmountOwned>1021660.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>1.6</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001657660</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>ANCORA FAMILY WEALTH ADVISORS, LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>OH</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>6675.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>6675.00</sharedDispositivePower>
        <aggregateAmountOwned>6675.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Inverness Holdings LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>6675.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>6675.00</sharedDispositivePower>
        <aggregateAmountOwned>6675.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Ancora Holdings Group, LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>OH</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4336575.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4336575.00</sharedDispositivePower>
        <aggregateAmountOwned>4336575.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.7</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001498290</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>DiSanto Frederick D.</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>4000.00</soleVotingPower>
        <sharedVotingPower>4336575.00</sharedVotingPower>
        <soleDispositivePower>4000.00</soleDispositivePower>
        <sharedDispositivePower>4336575.00</sharedDispositivePower>
        <aggregateAmountOwned>4340575.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.7</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>Green Plains Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>1811 AKSARBEN DRIVE</com:street1>
          <com:city>OMAHA</com:city>
          <com:stateOrCountry>NE</com:stateOrCountry>
          <com:zipCode>68106</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>The following constitutes Amendment No. 5 to the Schedule 13D filed by the undersigned ("Amendment No. 5"). This Amendment No. 5 amends the Schedule 13D as specifically set forth herein.</commentText>
      </item1>
      <item2>
        <filingPersonName>Item 2(a) is amended and restated to read as follows:

This statement is filed by:

(i) Ancora Merlin, LP, a Delaware limited partnership ("Ancora Merlin"), with respect to the Shares directly and beneficially owned by it;

(ii) Ancora Merlin Institutional, LP, a Delaware limited partnership ("Ancora Merlin Institutional"), with respect to the Shares directly and beneficially owned by it;

(iii) Ancora Catalyst, LP, a Delaware limited partnership ("Ancora Catalyst"), with respect to the Shares directly and beneficially owned by it;

(iv) Ancora Catalyst Institutional, LP, a Delaware limited partnership ("Ancora Catalyst Institutional"), with respect to the Shares directly and beneficially owned by it;

(v) Ancora Bellator Fund LP, a Delaware limited partnership ("Ancora Bellator"), with respect to the Shares directly and beneficially owned by it;

(vi) Ancora Impact Fund LP - Series Q, a series of Ancora Impact Fund LP, a Delaware limited partnership ("Ancora Impact Q"), with respect to the Shares directly and beneficially owned by it;

(vii) Ancora Impact Fund LP - Series S, a series of Ancora Impact Fund LP, a Delaware limited partnership ("Ancora Impact S" and together with Ancora Merlin, Ancora Merlin Institutional, Ancora Catalyst, Ancora Catalyst Institutional, Ancora Bellator and Ancora Impact Q, the "Ancora LP Funds"), with respect to the Shares directly and beneficially owned by it;

(viii) Ancora Impact Fund SPC Ltd. - Segregated Portfolio H, a Cayman Islands segregated portfolio company ("Ancora SPC H" and together with the Ancora LP Funds, the "Ancora Funds"), with respect to the Shares directly and beneficially owned by it;

(ix) Ancora Alternatives LLC, an Ohio limited liability company ("Ancora Alternatives"), as the general partner of each of the Ancora LP Funds and as the investment advisor to each of the Ancora Funds and certain separately managed accounts (the "Ancora Alternatives SMAs");

(x) Ancora Family Wealth Advisors, LLC, an Ohio limited liability company ("Ancora Family Wealth"), as the investment advisor of to certain separately managed accounts (the "Ancora Family Wealth SMAs");

(xi) Inverness Holdings LLC, a Delaware limited liability company ("Inverness Holdings"), as the sole member of Ancora Family Wealth;

(xii) Ancora Holdings Group, LLC, a Delaware limited liability company ("Ancora Holdings"), as the sole member of Ancora Alternatives and Inverness Holdings; and

(xiii) Fredrick DiSanto, as the Chairman and Chief Executive Officer of Ancora Holdings.

Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Each of the Reporting Persons is party to the Joint Filing Agreement as further described in Item 6 below. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.

Set forth on Exhibit 1 annexed hereto ("Exhibit 1") is the name and present principal occupation or employment, principal business address and citizenship of the executive officers and directors of Ancora SPC H. To the best of the Reporting Persons' knowledge, except as otherwise set forth herein, none of the persons listed on Exhibit 1 beneficially owns any securities of the Issuer or is a party to any contract, agreement or understanding required to be disclosed herein.</filingPersonName>
        <principalBusinessAddress>Item 2(b) is amended and restated to read as follows:

The address of the principal office of each of the Ancora Funds, Ancora Alternatives, Ancora Family Wealth, Inverness Holdings, Ancora Holdings and Mr.DiSanto is 6060 Parkland Boulevard, Suite 200, Cleveland, Ohio 44124.</principalBusinessAddress>
        <principalJob>Item 2(c) is amended and restated to read as follows:

The principal business of each of the Ancora Funds is investing in securities. The principal business of Ancora Alternatives is serving as the general partner of each of the Ancora LP Funds and as the investment advisor of each of the Ancora Funds and the Ancora Alternatives SMAs. The principal business of Ancora Family Wealth is serving as the investment advisor of the Ancora Family Wealth SMAs. The principal business of Inverness Holdings is serving as the sole member of Ancora Family Wealth. The principal business of Ancora Holdings is serving as the sole member of Ancora Alternatives and Inverness Holdings. The principal occupation of Mr. DiSanto is serving as the Chairman and Chief Executive Officer of Ancora Holdings.</principalJob>
        <hasBeenConvicted>Item 2(d) is amended and restated to read as follows:

No Reporting Person, nor any person listed on Exhibit 1, has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>Item 2(e) is amended and restated to read as follows:

No Reporting Person, nor any person listed on Exhibit 1, has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>Item 2(f) is amended and restated to read as follows:

Mr. DiSanto is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <fundsSource>Item 3 is hereby amended and restated to read as follows:

The Shares purchased by each of the Ancora Funds and held in the Ancora Alternatives SMAs and the Ancora Family Wealth SMAs were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 33,024 Shares owned directly by Ancora Merlin is approximately $978,080, including brokerage commissions. The aggregate purchase price of the 575,965 Shares owned directly by Ancora Merlin Institutional is approximately $11,805,555, including brokerage commissions. The aggregate purchase price of the 46,744 Shares owned directly by Ancora Catalyst is approximately $1,242,141, including brokerage commissions. The aggregate purchase price of the 568,378 Shares owned directly by Ancora Catalyst Institutional is approximately $13,179,954, including brokerage commissions. The aggregate purchase price of the 364,641 Shares owned directly by Ancora Bellator is approximately 6,763,027, including brokerage commissions. The aggregate purchase price of the 400,904 Shares owned directly by Ancora Impact Q is approximately $13,128,656, including brokerage commissions. The aggregate purchase price of the 822,563 Shares owned directly by Ancora Impact S is approximately $26,603,631, including brokerage commissions. The aggregate purchase price of the 1,021,660 Shares owned directly by Ancora SPC H is approximately $33,072,334, including brokerage commissions. The aggregate purchase price of the 496,021 Shares held in the Ancora Alternatives SMAs is approximately $13,428,743, including brokerage commissions. The aggregate purchase price of the 6,675 Shares held in the Ancora Family Wealth SMAs is approximately $89,930, including brokerage commissions.

The Shares purchased by Mr. DiSanto were purchased in the open market with personal funds. The aggregate purchase price of the 4,000 shares beneficially owned by Mr. DiSanto is approximately $49,178, including brokerage commissions.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 is hereby amended to add the following:

On April 11, 2025, Ancora Holdings entered into a cooperation agreement (the "Cooperation Agreement") with the Issuer, pursuant to which, among other things, the Issuer agreed, as soon as reasonably practicable after the date of the Cooperation Agreement but in no event later than three business days after the date thereof, to take all necessary actions to increase the size of the Issuer's Board of Directors (the "Board") from eight to ten and to appoint as members of the Board Patrick Sweeney, Carl Grassi and Steve Furcich (the "New Directors"). Pursuant to the Cooperation Agreement, the Issuer agreed to take all necessary actions to accept the retirement of two incumbent members of the Board who have each served as directors for at least five years, with such retirements to be effective as of the conclusion of the Issuer's 2025 annual meeting of shareholders (the "2025 Annual Meeting").

The Cooperation Agreement also provides that the Issuer will form a Strategic Planning Committee of the Board to provide analysis and recommendations to the Board pertaining to cost optimization, capital allocation, capital structure and other finance matters and transaction opportunities, which committee will comprise four directors, including two of the New Directors, and that it will appoint Mr. Grassi to the Nominating and Governance Committee of the Board concurrent with his appointment to the Board. The Issuer also agreed to use its best efforts to hold the 2025 Annual Meeting on or before June 7, 2025, and to include the New Directors in its slate of nominees at the 2025 Annual Meeting.

The Issuer further agreed, from the date of the Cooperation Agreement until its termination, not to increase the size of the Board, prior to the appointment of a new Chief Executive Officer of the Issuer, to more than ten directors and after such appointment, to more than 11 directors, in each case without the prior written consent of Ancora Holdings. Ancora Holdings was also granted customary replacement rights in the event that any of the New Directors cease to serve as a director.

During the term of the Cooperation Agreement, the Reporting Persons have agreed to vote all Voting Securities (as defined in the Cooperation Agreement) beneficially owned by them at all meetings of the Issuer's shareholders in accordance with the Board's recommendations, except that the Reporting Persons (a) may vote in their discretion on any proposal of the Issuer in respect of any Extraordinary Transaction (as defined in the Cooperation Agreement), share issuance or the implementation of takeover defenses not in existence as of the date of the Cooperation Agreement and (b)will be permitted to vote in accordance with the recommendation of Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis &amp; Co., LLC ("Glass Lewis") if ISS and Glass Lewis issue a voting recommendation that differs from the Board's recommendation with respect to any proposal submitted to shareholders at a shareholder meeting (other than any proposal related to director elections, removals or replacements).

The Reporting Persons have also agreed to certain customary standstill provisions prohibiting them from, among other things, (a) soliciting proxies; (b) advising or knowingly encouraging any person with respect to the voting or disposition of any securities of the Issuer, subject to limited exceptions; (c) beneficially owning more than 9.9% of the then-outstanding Shares and (d) taking actions to change or influence the Board, management or the direction of certain matters related to the Issuer; in each case as further described in the Cooperation Agreement.

The Cooperation Agreement will terminate on the date that is the earlier of (a) 30 days prior to the notice deadline under the Issuer's Fifth Amended and Restated Bylaws for the submission of shareholder director nominations for the Issuer's 2026 annual meeting of shareholders and (b) 100 days prior to the first anniversary of the 2025 Annual Meeting.

The foregoing description of the Cooperation Agreement does not purport to be complete and is qualified in its entirety by reference to the Cooperation Agreement, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Item 5(a) is hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each person named herein is based upon 64,729,446 Shares outstanding as of February 4, 2025, as disclosed in the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 7, 2025.

As of the date hereof, Ancora Merlin beneficially owned directly 33,024 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Merlin Institutional beneficially owned directly 575,965 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Catalyst beneficially owned directly 46,744 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Catalyst Institutional beneficially owned directly 568,378 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Bellator beneficially owned directly 364,641 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Impact Q beneficially owned directly 400,904 Shares, constituting 0% of the Shares outstanding.

As of the date hereof, Ancora Impact S beneficially owned directly 822,563 Shares, constituting approximately 1.3% of the Shares outstanding.

As of the date hereof, Ancora SPC H beneficially owned directly 1,021,660 Shares, constituting approximately 1.6% of the Shares outstanding.

As of the date hereof, Ancora Alternatives, as the investment advisor to each of the Ancora Funds and the Ancora Alternatives SMAs and the general partner of each of the Ancora LP Funds, may be deemed to beneficially own 4,329,900 Shares, constituting approximately 6.7% of the Shares outstanding and consisting of (i) 33,024 Shares beneficially owned directly by Ancora Merlin, (ii) 575,965 Shares beneficially owned directly by Ancora Merlin Institutional, (iii) 46,744 Shares beneficially owned directly by Ancora Catalyst, (iv) 568,378 Shares beneficially owned directly by Ancora Catalyst Institutional, (v) 364,641 Shares beneficially owned directly by Ancora Bellator, (vi) 400,904 Shares beneficially owned directly by Ancora Impact Q, (vii) 822,563 Shares beneficially owned directly by Ancora Impact S, (viii) 1,021,660 Shares beneficially owned directly by Ancora SPC H and (ix) 496,021 Shares held in the Ancora Alternatives SMAs.

As of the date hereof, Ancora Family Wealth, as the investment advisor to the Ancora Family Wealth SMAs, may be deemed to beneficially own 6,675 Shares, constituting 0% of the Shares outstanding and consisting of 6,675 Shares held in the Ancora Family Wealth SMAs.

As of the date hereof, Inverness Holdings, as the sole member of Ancora Family Wealth, may be deemed to beneficially own 6,675 Shares, constituting 0% of the Shares outstanding and consisting of 6,675 Shares held in the Ancora Family Wealth SMAs.

As of the date hereof, Ancora Holdings, as the sole member of each of Ancora Alternatives and Inverness Holdings, may be deemed to beneficially own 4,336,575 Shares, constituting approximately 6.7% of the Shares outstanding and consisting of (i) 33,024 Shares beneficially owned directly by Ancora Merlin, (ii) 575,965 Shares beneficially owned directly by Ancora Merlin Institutional, (iii) 46,744 Shares beneficially owned directly by Ancora Catalyst, (iv) 568,378 Shares beneficially owned directly by Ancora Catalyst Institutional, (v) 364,641 Shares beneficially owned directly by Ancora Bellator, (vi) 400,904 Shares beneficially owned directly by Ancora Impact Q, (vii) 822,563 Shares beneficially owned directly by Ancora Impact S, (viii) 1,021,660 Shares beneficially owned directly by Ancora SPC H (ix) 496,021 Shares held in the Ancora Alternatives SMAs and (x) 6,675 Shares held in the Ancora Family Wealth SMAs.

As of the date hereof, Mr. DiSanto beneficially owned directly 4,000 Shares. As the Chairman and Chief Executive Officer of Ancora Holdings, he may be deemed to beneficially own 4,336,575 Shares, constituting approximately 6.7% of the Shares outstanding and consisting of (i) 33,024 Shares beneficially owned directly by Ancora Merlin, (ii) 575,965 Shares beneficially owned directly by Ancora Merlin Institutional, (iii) 46,744 Shares beneficially owned directly by Ancora Catalyst, (iv) 568,378 Shares beneficially owned directly by Ancora Catalyst Institutional, (v) 364,641 Shares beneficially owned directly by Ancora Bellator, (vi) 400,904 Shares beneficially owned directly by Ancora Impact Q, (vii) 822,563 Shares beneficially owned directly by Ancora Impact S, (viii) 1,021,660 Shares beneficially owned directly by Ancora SPC H (ix) 496,021 Shares held in the Ancora Alternatives SMAs and (x) 6,675 Shares held in the Ancora Family Wealth SMAs.</percentageOfClassSecurities>
        <numberOfShares>Item 5(b) is hereby amended and restated to read as follows:

(i) Ancora Merlin
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 33,024
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 33,024

(ii) Ancora Merlin Institutional
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 575,965
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 575,965

(iii) Ancora Catalyst
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 46,744
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 46,744

(iv) Ancora Catalyst Institutional
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 568,378
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 568,378

(v) Ancora Bellator
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 364,641
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 364,641

(vi) Ancora Impact Q
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 400,904
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 400,904

(vii) Ancora Impact S
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 822,563
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 822,563

(viii) Ancora SPC H
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,021,660
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,021,660

(ix) Ancora Alternatives
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 4,329,900
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 4,329,900

(x) Ancora Family Wealth
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 6,675
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 6,675

(xi) Inverness Holdings
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 6,675
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 6,675

(xii) Ancora Holdings
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 4,336,575
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 4,336,575

(xiii) Mr. DiSanto
1. Sole power to vote or direct vote: 4,000
2. Shared power to vote or direct vote: 4,336,575
3. Sole power to dispose or direct the disposition: 4,000
4. Shared power to dispose or direct the disposition: 4,336,575</numberOfShares>
        <transactionDesc>Item 5(c) is hereby amended and restated to read as follows:

The transactions in the Shares by the Reporting Persons during the past sixty days are set forth in Exhibit 2 and are incorporated herein by reference. All of such transactions were effected in the open market unless otherwise noted.</transactionDesc>
      </item5>
      <item6>
        <contractDescription>Item 6 is hereby amended to add the following:

On April 11, 2025, Ancora Holdings and the Issuer entered into the Cooperation Agreement, as defined and described in Item 4 above, which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

On April 15, 2025, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Item 7 is hereby amended to add the following exhibits:

1 - Directors and Officers of Ancora SPC H

2 - Transactions in the Securities of the Issuer During the Past 60 days

99.1 - Cooperation Agreement

99.2 - Joint Filing Agreement dated April 15, 2025</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Ancora Alternatives LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Merlin, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>ANCORA MERLIN INSTITUTIONAL, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Catalyst, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Catalyst Institutional, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Bellator Fund, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Impact Fund LP - Series Q</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Impact Fund LP - Series S</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Impact Fund SPC Ltd. - Segregated Portfolio H</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>ANCORA FAMILY WEALTH ADVISORS, LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Inverness Holdings LLC, Sole Member</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Inverness Holdings LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ancora Holdings Group, LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto, Chair and CEO</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>DiSanto Frederick D.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fredrick DiSanto</signature>
          <title>Fredrick DiSanto</title>
          <date>04/15/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1to13da506470035_041525.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Directors and Officers of Ancora Impact Fund
SPC Ltd. &ndash; Segregated Portfolio H</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><U>Name and Position</U></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><U>Principal Occupation</U></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><U>Principal Business Address</U></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><U>Citizenship</U></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Bradley Zucker<BR>
Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Company Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">6060 Parkland Boulevard<BR>
Suite 200<BR>
Cleveland, Ohio 44124</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">United States</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Julie O&rsquo;Hara<BR>
Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Company Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">94 Solaris Avenue<BR>
Box 1348, Camana Bay<BR>
Grand Cayman<BR>
Cayman Islands <BR>
KY1-1108</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Canada</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Ronan Guilfoyle<BR>
Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Company Director</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">94 Solaris Avenue<BR>
Box 1348, Camana Bay<BR>
Grand Cayman<BR>
Cayman Islands <BR>
KY1-1108</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Ireland</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>3
<FILENAME>ex2to13da506470035_041525.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Transactions in Securities of the Issuer
During the Past Sixty Days</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><U>Nature of Transaction</U></TD>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Amount of Securities<U><BR>
Purchased/(Sold)</U></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><U>Price per Security ($)</U></TD>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date of<BR>
<U>Purchase/Sale</U></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANCORA MERLIN INSTITUTIONAL, LP</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">20,950</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7.0038</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">137,357</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.5150</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">23,206</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.3376</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/11/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANCORA CATALYST INSTITUTIONAL, LP</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">8,300</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7.0055</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">54,422</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.5150</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">9,195</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.3391</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/11/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANCORA BELLATOR FUND LP</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">4,152</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7.0043</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">27,221</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.5151</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">4,599</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.3380</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/11/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANCORA IMPACT FUND LP SERIES Q</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(25,336)</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.4948</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(3,864)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.8954</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(16,371)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.2768</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/11/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANCORA IMPACT FUND LP SERIES S</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(193,664)</TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.4948</TD>
    <TD STYLE="white-space: nowrap; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(29,538)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.8951</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/10/2025</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(20,629)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6.2768</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/11/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex991to13da506470035_041525.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 99.1<I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><I>EXECUTION VERSION</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">COOPERATION AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Cooperation Agreement
(this &ldquo;<B>Agreement</B>&rdquo;), effective as of April 11, 2025 (the&nbsp;&ldquo;<B>Effective Date</B>&rdquo;), is entered into
by and between Green Plains Inc., an Iowa corporation (the&nbsp;&ldquo;<B>Company</B>&rdquo;), and Ancora Holdings Group, LLC, a Delaware
limited liability company (collectively with its Affiliates and Associates, the &ldquo;<B>Investor</B>&rdquo;). The Company and the Investor
are together referred to herein as the &ldquo;<B>Parties</B>,&rdquo; and each of the Company and the Investor, respectively, a &ldquo;<B>Party.</B>&rdquo;
Unless otherwise defined herein, capitalized terms shall have the meanings given to them in <U>Section&nbsp;17</U> herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, as of the
Effective Date, the Investor beneficially owns an aggregate of 4,340,575 shares of common stock, par value $0.001 per share, of the Company
(the &ldquo;<B>Common Stock</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and the Investor desire to enter into this Agreement regarding compositional changes to the board of directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
and certain other matters, as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the promises, representations and mutual covenants and agreements set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Board
Composition and Other Company Matters</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Directors</U>. As soon as reasonably practicable following the Effective Date but in any event no later than three (3) business days from
the date hereof, the Board, and all applicable committees of the Board, shall take all necessary actions to increase the size of the Board
from eight (8) to ten (10) directors and appoint as members of the Board each of (i) Patrick Sweeney (the &ldquo;<B>First New Ancora Director</B>&rdquo;),
who shall fill one (1) of the newly created vacancies resulting from the increase in the size of the Board, (ii)&nbsp;Carl Grassi (the
&ldquo;<B>Second New Ancora Director</B>,&rdquo;&nbsp;and together with the First New Ancora Director, the &ldquo;<B>New Ancora Directors</B>,&rdquo;
and each, a &ldquo;<B>New Ancora Director</B>&rdquo;), who shall fill one (1) of the newly created vacancies resulting from the increase
in the size of the Board, and (iii)&nbsp;Steve Furcich, who is mutually agreeable to the Company and the Investor (the&nbsp;&ldquo;<B>Third
New Director</B>,&rdquo; and collectively with the First New Ancora Director and the Second New Ancora Director, the &ldquo;<B>New Directors</B>,&rdquo;
and each, a &ldquo;<B>New Director</B>&rdquo;), who shall fill the vacancy resulting from Todd Becker&rsquo;s resignation from the Board,
as described below in <U>Section 2</U> herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Size</U>. During the Standstill Period, the Board and all applicable committees of the Board shall not increase the size of the Board
(i) prior to the appointment of the newly hired Chief Executive Officer to the Board, as set forth in <U>Section 2</U> below, to more
than ten (10) directors and (ii) after such appointment and prior to the expiration of the Standstill Period, to more than eleven (11)
directors, in each case without the prior written consent of the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Director
Independence</U>. The Parties acknowledge that prior to the Effective Date, (i) the Board shall have determined whether each New Director
is an &ldquo;Independent Director,&rdquo; as defined in the listing rules of the NASDAQ Stock Market LLC (or applicable requirement of
such other national securities exchange designated as the primary market on which the Common Stock is listed for trading), (ii) each New
Director (A)&nbsp;shall have provided (x)&nbsp;such information required to be or customarily disclosed by directors or director candidates
in proxy statements or other filings under applicable law or stock exchange regulations, (y)&nbsp;such information reasonably requested
by the Board in connection with assessing eligibility, independence and other criteria applicable to directors or satisfying compliance
and legal obligations and (z)&nbsp;a fully completed and executed copy of the Company&rsquo;s director candidate questionnaire (substantially
in the form completed by the Company&rsquo;s incumbent non-management directors) and (B)&nbsp;shall have participated in customary procedures
for new director candidates, including an appropriate background check, comparable to those undergone by other non-management directors
of the Company and an interview with the Nominating and Governance Committee of the Board (the&nbsp;&ldquo;<B>Nominating Committee</B>&rdquo;
and the actions, determinations and obligations constituting (i) and (ii) of this <U>Section 1(c)</U>, the&nbsp;&ldquo;<B>Review Process</B>&rdquo;),
(iii)&nbsp;the Nominating Committee, following the Review Process, shall have determined to recommend (the&nbsp;&ldquo;<B>Affirmative
Committee Recommendation</B>&rdquo;) that the Board include each New Director in the Company&rsquo;s slate of nominees for election as
a director of the Company at the 2025 annual meeting of shareholders (including, but not limited to, any adjournments or postponements
thereof and any meeting which may be called in lieu thereof, the &ldquo;<B>2025 Annual Meeting</B>&rdquo;) and (iv)&nbsp;the Board shall
have accepted such Affirmative Committee Recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Director
Elections</U>. The Company shall include the New Directors (or any Replacement Director (as defined below) thereof, as applicable) in
the Company&rsquo;s slate of nominees for election as directors of the Company at the 2025 Annual Meeting and shall use commercially reasonable
efforts to cause the election of the New Directors (or any Replacement Director, as applicable) to the Board at the 2025 Annual Meeting
(including the Board recommending that the Company&rsquo;s shareholders vote in favor of the election of the New Directors (or any Replacement
Director, as applicable) in the Company&rsquo;s proxy statement for the 2025 Annual Meeting and otherwise supporting the New Directors
(or any Replacement Director, as applicable) for election in a manner no less rigorous and favorable than the manner in which the Company
supports its other nominees in the aggregate); <U>provided</U>, <U>however</U>, that if such director is a Replacement Director, then,
prior to both (i) any such inclusion of the Replacement Director in the Company&rsquo;s slate of nominees and (ii) the use of any efforts
by the Company to cause the election of such Replacement Director, for any such Replacement Director, the actions, determinations and
obligations of the Review Process shall have been completed, the Nominating Committee shall have made the Affirmative Committee Recommendation,
and the Board shall have accepted such Affirmative Committee Recommendation (such acceptance not to be unreasonably withheld).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement
of New Directors</U>. If, during the Standstill Period, any New Director resigns from the Board or is rendered unable (due to death or
disability) to, or refuses to, serve on the Board, and at all times since the date of this Agreement and at such time as the Investor&rsquo;s
aggregate beneficial ownership of Common Stock equals or exceeds the Minimum Ownership Threshold, then the Investor shall have the right
to identify a replacement (who shall qualify as an &ldquo;Independent Director,&rdquo; as defined in the listing rules of the NASDAQ Stock
Market LLC (or applicable requirement of such other national securities exchange designated as the primary market on which the Common
Stock is listed for trading) and participate in the Review Process as described under <U>Section&nbsp;1(c)</U> hereof) to fill the resulting
vacancy caused by such New Director&rsquo;s departure from the Board and any such person shall be promptly appointed to the Board, subject
to the good faith review and approval of such person (such approval not to be unreasonably conditioned, withheld or delayed) by the Nominating
Committee (any such replacement director, a&nbsp;&ldquo;<B>Replacement Director</B>&rdquo;)&#894; <U>provided</U>, that (i) solely in
the case of a Replacement Director replacing the Second New Director, such Replacement Director shall not be an employee of the Investor
and (ii) solely in the case of a Replacement Director replacing the Third New Director, such Replacement Director shall be mutually agreeable
between the Parties. Upon a Replacement Director&rsquo;s appointment to the Board, such Replacement Director shall be deemed to be a New
Director for all purposes under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Retiring
Directors</U>. To the extent permissible under applicable law, including, but not limited to, legal duties or obligations of directors
of corporations incorporated under Iowa law, the Board, and all applicable committees of the Board, shall take all necessary actions to
accept the retirements of two (2) incumbent members of the Board who have each served as directors of the Board for at least five years
in their capacities as directors of the Board and such retirements shall be effective as of the conclusion of the 2025 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Board Committee</U>. The Board, and all applicable committees of the Board, shall take all necessary actions to form a Strategic Planning
Committee of the Board (the&nbsp;&ldquo;<B>Strategic Planning Committee</B>&rdquo;) for the sole purpose of providing analysis and non-binding
recommendations to the Board pertaining to cost optimization, capital allocation, capital structure and other finance matters and transaction
opportunities (the&nbsp;&ldquo;<B>Committee Purpose</B>&rdquo;). The Company agrees that the Board, and all applicable committees of the
Board, shall take all necessary actions to constitute the Strategic Planning Committee to comprise four (4) directors, which shall include
two (2) of the New Directors and two (2) directors chosen by the Company. The Board, and all applicable committees of the Board, shall
take all necessary actions to adopt a charter of the Strategic Planning Committee that is consistent with, and limited to, the Committee
Purpose as stated in this <U>Section 1(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Committees</U>. Concurrently with the appointment of the Second New Ancora Director to the Board, the Board, and all applicable committees
of the Board, shall take all necessary actions to appoint the Second New Ancora Director to the Nominating Committee. Without limiting
the foregoing, the New Directors shall be given the same consideration for membership to any committees of the Board as any other independent
director with similar relevant expertise and qualifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Policies and Procedures</U>. Each Party acknowledges that each New Director, upon his appointment to the Board and for so long as he is
a member of the Board, shall be governed by all of the same policies, processes, procedures, codes, rules, standards and guidelines applicable
to members of the Board, including, but not limited to, the Company&rsquo;s Code of Business Ethics and Conduct, Corporate Governance
Guidelines, Insider Trading Policy and any other policies on stock ownership, public disclosures, legal compliance and confidentiality
(collectively, the&nbsp;&ldquo;<B>Company Policies</B>&rdquo;) and all applicable rules and regulations of the NASDAQ Stock Market LLC
(including, but not limited to, its independence standards), and will be required to strictly adhere to the Company&rsquo;s policies on
confidentiality imposed on all members of the Board. The Company agrees that, upon his appointment to the Board and for so long as he
is a member of the Board, each New Director shall receive (i)&nbsp;the same benefits of director and officer insurance as all other&nbsp;non-management&nbsp;directors
on the Board, (ii)&nbsp;the same compensation for his service as a director as the compensation received by other&nbsp;non-management&nbsp;directors
on the Board and (iii)&nbsp;such other benefits on the same basis as all other&nbsp;non-management&nbsp;directors on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Resignation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent permissible under applicable law, including, but not limited to, legal duties or obligations of directors of corporations incorporated
under Iowa law, and as a condition to the appointment of the First New Ancora Director, the First New Ancora Director shall submit to
the Company an irrevocable letter of resignation as a member of the Board, substantially in the form attached hereto as <U>Exhibit A</U>,
which shall become effective, if and when accepted by the Board, in the Board&rsquo;s sole discretion, (A) following receipt by the Company
of notice that the Investor&rsquo;s aggregate beneficial ownership of Common Stock fails to exceed the Minimum Ownership Threshold; or
(B) if the Investor commits a material breach of its obligations under <U>Section 7</U> hereof with such material breach (x) not capable
of being cured or (y) if capable of being cured, not cured within fifteen (15)&nbsp;days after receipt by the Investor from the Company
of written notice specifying the material breach, then following a final judgment (affirming such material breach of (x) or (y) of this
<U>Section 1(j)(i)</U>) in an action brought in a court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Standstill Period, the Investor shall reasonably monitor its aggregate beneficial ownership of Common Stock to maintain its awareness
of whether it meets the Minimum Ownership Threshold. The Investor shall notify the Company in writing promptly, but in no event later
than five (5) business days, after becoming aware of the Investor&rsquo;s aggregate beneficial ownership failing to equal or exceed the
Minimum Ownership Threshold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>2025
Annual Meeting</U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">. The Company shall use its best efforts
to hold the 2025 Annual Meeting on or before June 7, 2025, subject to any delay necessitated by compliance with applicable law or regulatory
or judicial or stock exchange order, published interpretation or requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Management
Succession</U></B></FONT>. Following the appointment of the New Directors, the then-newly constituted Board shall participate in the ongoing
Chief Executive Officer succession planning process currently being performed by the Nominating Committee. Following the conclusion of
the search and identification process for a new Chief Executive Officer, and, as necessary to accommodate the appointment of the newly
hired Chief Executive Officer to the Board, the newly constituted Board shall (a) increase the size of the Board by one (1) and (b) appoint
the new Chief Executive Officer to the Board to fill the newly created vacancy resulting from the increase in the size of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Voting</U></B></FONT>.
From the Effective Date until the Termination Date (the &ldquo;<B>Standstill Period</B>&rdquo;), the Investor agrees that it shall, or
shall cause its Representatives to, appear in person or by proxy at each annual or special meeting of shareholders of the Company (including,
but not limited to, any adjournments or postponements thereof and any meetings which may be called in lieu thereof), whether such meeting
is held at a physical location or virtually by means of remote communications, and will vote (or execute a consent with respect to) all
Voting Securities beneficially owned by it or its Affiliates in accordance with the Board&rsquo;s recommendations with respect to any
and all proposals, including, but not limited to, proposals related to director elections, removals or replacements; <U>provided</U>,
<U>however</U>, that if Institutional Shareholder Services Inc. (&ldquo;<B>ISS</B>&rdquo;) and Glass Lewis &amp; Co. LLC (&ldquo;<B>Glass
Lewis</B>&rdquo;) issue a voting recommendation that differs from the Board&rsquo;s recommendation with respect to any proposal submitted
to shareholders at a shareholder meeting (other than any proposal related to director elections, removals or replacements), the Investor
shall be permitted to vote in accordance with ISS&rsquo;s and Glass Lewis&rsquo;s recommendation; <U>provided</U>, <U>further</U>, that
the Investor may vote in its discretion on any proposal of the Company in respect of any Extraordinary Transaction, share issuance, or
the implementation of takeover defenses not in existence as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Mutual
Non-Disparagement</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until
the Termination Date, neither Party shall, nor shall it permit any of its Representatives to, directly or indirectly, in any capacity
or manner, make, transmit or otherwise communicate any statement of any kind (public or otherwise), or take any action that is intended
to result in a statement of any kind (public or otherwise), whether verbal, in writing, electronically transferred or otherwise, including,
but not limited to, any member of the media, that constitutes an <I>ad hominem</I> attack on, or otherwise disparages, defames or damages
the other Party (including, but not limited to, in each case its current and former directors, officers, employees and Affiliates).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, nothing in this <U>Section&nbsp;4</U> or elsewhere in this Agreement shall prohibit either Party from making any factual
statement or disclosure required under the federal securities laws, the rules of any self-regulatory organization or other applicable
laws (including, but not limited to, to comply with (i)&nbsp;any valid subpoena or other legal process from any court, governmental body
or regulatory authority, in each case, with competent jurisdiction over the relevant Party hereto, or (ii)&nbsp;any deposition, interrogatory,
request for documents, civil investigative demand or other similar process) or stock exchange regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
limitations set forth in <U>Section&nbsp;4(a)</U> shall not prevent either Party from responding to any public statement made by the other
Party of the nature described in <U>Section&nbsp;4(a)</U>, if such statement by the other Party was made in breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>No
Litigation</U></B></FONT>. Each Party hereby covenants and agrees that, prior to the Termination Date and except in the case of fraud
by the Company or the Investor, it shall not, and shall not permit any of its Representatives (solely in the context of their representation
of such Party in connection with the subject matter of this Agreement) to, directly or indirectly, alone or in concert with others, encourage,
pursue, or assist any other person to threaten, initiate or pursue any lawsuit, claim or proceeding (including, but not limited to, with
respect to the Investor, commencing, encouraging or supporting any derivative action in the name of the Company or any class action against
the Company or any of its directors or officers, in each case with the intent of circumventing any terms of this Agreement) before any
Governmental Authority (each, a &ldquo;<B>Legal Proceeding</B>&rdquo;) against the other Party or any of its Representatives (solely in
the context of their representation of such Party in connection with the subject matter of this Agreement), except for (a)&nbsp;any Legal
Proceeding initiated primarily to remedy a breach of or to enforce this Agreement, (b)&nbsp;counterclaims with respect to any proceeding
initiated by or on behalf of one Party or its Affiliates against the other Party or its Affiliates or (c)&nbsp;any Legal Proceeding with
respect to claims of fraud in connection with, arising out of or related to this Agreement; <U>provided</U>, <U>however</U>, that the
foregoing shall not prevent either Party or any of its Representatives from responding to oral questions, interrogatories, requests for
information or documents, subpoenas, civil investigative demands or similar processes (each, a &ldquo;<B>Legal Requirement</B>&rdquo;)
in connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, on behalf of, or at the direct or indirect
suggestion of such Party or any of its Representatives (solely in the context of their representation of such Party in connection with
the subject matter of this Agreement), except as provided in <U>Section&nbsp;6(e)</U>; <U>provided</U>, <U>further</U>, that in the event
either Party or any of its Representatives receives such Legal Requirement (solely with respect to the subject matter of this Agreement),
such Party shall, unless prohibited by applicable law, give prompt written notice of such Legal Requirement to the other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Releases</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Date, the Company permanently, fully and completely releases, acquits, and discharges the Investor, and the Investor&rsquo;s
Affiliates and Associates (including, but not limited to, in each case its current and former directors and officers), jointly or severally,
of and from any and all claims, demands, damages, causes of action, debts, liabilities, controversies, judgments, and suits of every kind
and nature whatsoever, foreseen, unforeseen, known or unknown, that the Company has had, now has, or may have against any of the Investor
and/or the Investor&rsquo;s Affiliates or Associates (including, but not limited to, in each case its current and former directors and
officers), collectively, jointly or severally, at any time prior to and including the Effective Date, including, but not limited to, any
and all claims arising out of or in any way whatsoever related to the Investor&rsquo;s involvement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Date, the Investor permanently, fully and completely releases, acquits and discharges the Company, and the Company&rsquo;s
Affiliates and Associates (including, but not limited to, in each case its current and former directors and officers), jointly or severally,
of and from any and all claims, demands, damages, causes of action, debts, liabilities, controversies, judgments, and suits of every kind
and nature whatsoever, foreseen, unforeseen, known or unknown, that the Investor has had, now has, or may have against any of the Company
and/or the Company&rsquo;s Affiliates or Associates (including, but not limited to, in each case its current and former directors and
officers), collectively, jointly or severally, at any time prior to and including the Effective Date, including, but not limited to, any
and all claims arising out of or in any way whatsoever related to the Investor&rsquo;s involvement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties each acknowledge that as of the time of the Effective Date, the Parties may have claims against one another that a Party does
not know or suspect to exist in its favor, including, but not limited to, claims that, had they been known, might have affected the decision
to enter into this Agreement, or to provide the releases set forth in this <U>Section&nbsp;6</U>. In connection with any such claims,
the Parties agree that they intend to waive, relinquish, and release any and all provisions, rights, and benefits any state or territory
of the United States or other jurisdiction that purports to limit the application of a release to unknown claims, or to facts unknown
at the time the release was entered into. In connection with this waiver, the Parties acknowledge that they, or any of them, may (including,
but not limited to, after the Effective Date) discover facts in addition to or different from those known or believed by them to be true
with respect to the subject matter of the releases set forth in this <U>Section&nbsp;6</U>, but it is the intention of the Parties to
complete, fully, finally, and forever compromise, settle, release, discharge, and extinguish any and all claims that they may have one
against another, known or unknown, suspected or unsuspected, contingent or absolute, accrued or unaccrued, apparent or unapparent, that
now exist or previously existed, without regard to the subsequent discovery of additional or different facts. The Parties acknowledge
that the foregoing waiver is a key, bargained-for element to this Agreement and the releases that are part of it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
releases provided for in this <U>Section&nbsp;6</U> are intended to be broad, and this breadth is a bargained-for feature of this Agreement.
Despite this, the releases provided for in this <U>Section&nbsp;6</U> are not intended to, and do not, extend to either Party&rsquo;s
obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything in this Agreement, including, but not limited to, this <U>Section&nbsp;6</U>, the Parties acknowledge and agree that this Agreement
does not waive, release, acquit or discharge any of the Company&rsquo;s claims that are or could be asserted in the litigation brought
by the Company currently pending in the District Court for the District of Nebraska and styled <I>Green Plains Inc. v. Chandler</I>, No.
8:23-cv-00438-JFB-SMB (D. Neb.) (the &ldquo;<B>Lawsuit</B>&rdquo;). Further, Investor agrees that, notwithstanding <U>Section&nbsp;5</U>
of this Agreement, (i)&nbsp;the Company&rsquo;s continued prosecution of the Lawsuit shall not be considered a breach or violation of
this Agreement, (ii)&nbsp;the Company and/or its Representatives may propound any subpoenas or other Legal Requirements in the Lawsuit,
including, but not limited to, Legal Requirements directed to Investor and/or its Representatives and (iii)&nbsp;Investor will respond
to such Legal Requirements as required by applicable law and will cooperate with the Company in responding to such Legal Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Standstill</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Standstill Period, the Investor agrees that it shall not, and shall cause its Affiliates and Associates not to, directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any public announcement or proposal with respect to, or publicly offer or propose, (A)&nbsp;any form of business combination or acquisition
or other transaction relating to a material amount of assets or securities of the Company or any of its subsidiaries, (B)&nbsp;any form
of restructuring, recapitalization or similar transaction with respect to the Company or any of its subsidiaries or (C)&nbsp;any form
of tender or exchange offer for shares of Common Stock or other Voting Securities, whether or not such transaction involves a Change of
Control of the Company; it being understood that the foregoing shall not prohibit the Investor or its Affiliates or Associates from (x)&nbsp;acquiring
Voting Securities, (y) selling or tendering their shares of Common Stock, and otherwise receiving consideration, pursuant to any such
transaction or (z) voting on any such transaction in accordance with <U>Section&nbsp;3</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;engage
in, or knowingly assist in the engagement in (including, but not limited to, engagement by use of or in coordination with a universal
proxy card), any solicitation of proxies or written consents to vote any Voting Securities, or conduct, or assist in the conducting of,
any type of binding or nonbinding referendum with respect to any Voting Securities, or assist or participate in any other way, directly
or indirectly, in any solicitation of proxies (or written consents) with respect to, or from the holders of, any Voting Securities, or
otherwise become a &ldquo;participant&rdquo; in a &ldquo;solicitation,&rdquo; as such terms are defined in Instruction&nbsp;3 of Item&nbsp;4
of Schedule&nbsp;14A and Rule&nbsp;14a-1 of Regulation 14A, respectively, under the Securities Exchange Act of 1934, as amended, and with
the rules and regulations thereunder (the&nbsp;&ldquo;<B>Exchange Act</B>&rdquo;), to vote any securities of the Company (including, but
not limited to, by initiating, encouraging or participating in any &ldquo;withhold&rdquo; or similar campaign), in each case other than
in a manner that is consistent with the Board&rsquo;s recommendation on a matter or as otherwise permitted by <U>Section 3</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;acquire
or offer, seek, propose or agree to acquire, whether by purchase, tender or exchange offer, through the acquisition of control of another
person, by joining a group, through swap or hedging transactions or otherwise, ownership (including beneficial ownership) of any securities
of the Company, any direct or indirect rights or options to acquire any such securities, any rights decoupled from the underlying securities
of the Company or any derivative securities, or contracts or instruments in any way related to the price of shares of Common Stock, or
any assets or liabilities of the Company, such that the Investors hold, directly or indirectly, in excess of 9.9% of the then-outstanding
shares of Common Stock of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;advise
or knowingly encourage any person with respect to the voting of (or execution of a written consent in respect of) or disposition of any
securities of the Company other than in a manner that is consistent with the Board&rsquo;s recommendation on a matter or in connection
with an Extraordinary Transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other
than in open market sale transactions where the identity of the purchaser is not known, sell, offer or agree to sell directly or indirectly,
through swap or hedging transactions or otherwise, the securities of the Company or any rights decoupled from the underlying securities
held by the Investor to any Third Party that would result in such Third Party, together with its Affiliates, owning, controlling or otherwise
having any, beneficial or other ownership interest representing in the aggregate in excess of 5.0% of the shares of Common Stock outstanding
at such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take
any action in support of or make any proposal or request that constitutes or would result in: (A)&nbsp;advising, replacing or influencing
any director or the management of the Company, including, but not limited to, any plans or proposals to change the number or term of directors
or to fill any vacancies on the Board, (B)&nbsp;any material change in the capitalization, stock repurchase programs and practices or
dividend policy of the Company, (C)&nbsp;any other material change in the Company&rsquo;s management, business or corporate structure,
(D)&nbsp;seeking to have the Company waive or make amendments or modifications to the Bylaws or the Articles of Incorporation, or other
actions that may impede or facilitate the acquisition of control of the Company by any person, (E)&nbsp;causing a class of securities
of the Company to be delisted from, or to cease to be authorized to be quoted on, any securities exchange, or (F)&nbsp;causing a class
of securities of the Company to become eligible for termination of registration pursuant to Section&nbsp;12(g)(4) of the Exchange Act
(in each case except as otherwise permitted by this Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;call
or seek to call, or request the call of, alone or in concert with others, any meeting of shareholders, whether or not such a meeting is
permitted by the Bylaws, including, but not limited to, a &ldquo;town hall meeting&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;deposit
any shares of Common Stock or other Voting Securities in any voting trust or subject any shares of Common Stock or other Voting Securities
to any arrangement or agreement with respect to the voting of any shares of Common Stock or Voting Securities (other than (A)&nbsp;any
such voting trust, arrangement or agreement solely among the Investor and its Affiliates that is otherwise in accordance with this Agreement
or (B)&nbsp;customary brokerage accounts, margin accounts, prime brokerage accounts and the like);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;seek,
or knowingly encourage or advise any person, to submit nominations in furtherance of a &ldquo;contested solicitation&rdquo; for the election
or removal of directors with respect to the Company or seek, or knowingly encourage or take any other action with respect to the election
or removal of any directors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;form,
join or in any other way participate in any &ldquo;group&rdquo; (within the meaning of Section&nbsp;13(d)(3) of the Exchange Act) with
respect to any Voting Security; <U>provided</U>, <U>however</U>, that nothing herein shall limit the ability of an Affiliate of the Investor
to join or in any way participate in the &ldquo;group&rdquo; currently in existence as of the Effective Date and comprising the Investor
following the execution of this Agreement, so long as any such Affiliate agrees to be subject to, and bound by, the terms and conditions
of this Agreement and, if required under the Exchange Act, files a Schedule&nbsp;13D or an amendment thereof, as applicable, within two
(2)&nbsp;business days after disclosing that the Investor has formed a group with such Affiliate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;demand
a copy of the Company&rsquo;s list of shareholders or its other books and records or make any request pursuant to Rule&nbsp;14a-7 under
the Exchange Act or under any statutory or regulatory provisions of Iowa providing for shareholder access to books and records (including,
but not limited to, lists of shareholders) of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;engage
any private investigations firm or other person to investigate any of the Company&rsquo;s directors or officers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;disclose
in a manner that could reasonably be expected to become public any intent, purpose, plan or proposal with respect to any of the Company&rsquo;s
directors or the Company&rsquo;s management, policies, strategy, operations, financial results or affairs, any of its securities or assets
or this Agreement that is inconsistent with the provisions of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any request or submit any proposal to amend or waive the terms of this <U>Section&nbsp;7</U> other than through non-public communications
with the Company that would not be reasonably likely to trigger public disclosure obligations for either Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take
any action challenging the validity or enforceability of any provisions in this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any discussions, negotiations, agreements or understandings with any Third Party with respect to any action the Investor is prohibited
from taking pursuant to this <U>Section&nbsp;7</U>, or advise, assist, knowingly encourage or seek to persuade any Third Party to take
any action or make any statement with respect to any such action, or otherwise take or cause any action or make any statement inconsistent
with any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything contained in <U>Section&nbsp;7(a)</U> or elsewhere in this Agreement, the Investor shall not be prohibited or restricted from:
(i)&nbsp;communicating privately with the Board or any officer or director of the Company regarding any matter, so long as such communications
are not intended to, and would not reasonably be expected to, require any public disclosure of such communications by either Party; (ii)&nbsp;making
any statement or taking any action to the extent required by applicable law, rule or regulation or legal process, subpoena or legal requirement
from any Governmental Authority with competent jurisdiction over the Investor or any national securities exchange designated as the primary
market on which the Common Stock is listed for trading, <U>provided</U>, that a breach by the Investor of this Agreement is not the cause
of the applicable requirement; or (iii)&nbsp;communicating privately with shareholders of the Company or others when such communication
is not made with an intent to otherwise violate, and would not be reasonably expected to result in a violation of, any provision of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Representations
and Warranties of the Company</U></B></FONT>. The Company represents and warrants to the Investor that (a)&nbsp;the Company has the corporate
power and authority to execute this Agreement and to bind it thereto, (b)&nbsp;this Agreement has been duly and validly authorized, executed
and delivered by the Company, constitutes a valid and binding obligation and agreement of the Company, and is enforceable against the
Company in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors and subject to general equity
principles, and (c)&nbsp;the execution, delivery and performance of this Agreement by the Company does not and will not violate or conflict
with (i)&nbsp;any law, rule, regulation, order, judgment or decree applicable to it, or (ii)&nbsp;result in any breach or violation of
or constitute a default (or an event which with notice or lapse of time or both could become a default) under or pursuant to, or result
in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational
document, or any material agreement, contract, commitment, understanding or arrangement to which the Company is a party or by which it
is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Representations
and Warranties of the Investor</U></B></FONT>. The Investor represents and warrants to the Company that (a)&nbsp;this Agreement has been
duly and validly authorized, executed and delivered by the Investor, and constitutes a valid and binding obligation and agreement of the
Investor, enforceable against the Investor in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors
and subject to general equity principles, (b)&nbsp;the signatory for the Investor has the power and authority to execute this Agreement
and any other documents or agreements entered into in connection with this Agreement on behalf of itself and the Investor, and to bind
the Investor to the terms hereof and thereof, and (c)&nbsp;the execution, delivery and performance of this Agreement by the Investor does
not and will not violate or conflict with (i)&nbsp;any law, rule, regulation, order, judgment or decree applicable to it, or (ii)&nbsp;result
in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could become a default)
under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or
cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which such member is a
party or by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>No
Other Discussions or Arrangements</U></B></FONT>. The Investor represents and warrants that, as of the Effective Date, except as publicly
disclosed in its SEC filings or otherwise specifically disclosed to the Company in writing prior to the Effective Date, (a)&nbsp;the Investor
does not own, of record or beneficially, any Voting Securities or any securities convertible into, or exchangeable or exercisable for,
any Voting Securities and (b)&nbsp;the Investor has not entered into, directly or indirectly, any agreements or understandings with any
person (other than its own Representatives) with respect to any potential transaction involving the Company or the voting or disposition
of any securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Press
Release and SEC Filings</U></B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
following the Effective Date, the Company shall issue a press release, substantially in the form attached hereto as <U>Exhibit B</U> (the
&ldquo;<B>Press Release</B>&rdquo;), announcing, among other things, certain terms of this Agreement, which shall include (i)&nbsp;the
addition of the three (3) New Directors to the Board and (ii)&nbsp;the formation of the Strategic Planning Committee. Neither the Company
nor the Investor shall make or cause to be made, and the Company and the Investor shall cause their respective Affiliates and Associates
not to make or cause to be made, any public announcement or statement with respect to the subject matter of this Agreement that is contrary
to the statements made in the Press Release or the terms of this Agreement without prior written consent of the other Party, except to
the extent required by law or the rules of any national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall file with the SEC a Current Report on Form 8-K reporting its entry into this Agreement and appending this Agreement as an
exhibit thereto (the &ldquo;<B>Form 8-K</B>&rdquo;). The Form 8-K shall be consistent with the terms of this Agreement. The Company shall
provide the Investor a reasonable opportunity to review and comment on the Form 8-K prior to the filing of the Form 8-K with the SEC and
shall consider in good faith any comments of the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
later than two (2)&nbsp;business days following the Effective Date, the Investor shall file with the SEC an amendment to its Schedule&nbsp;13D
in compliance with Section&nbsp;13 of the Exchange Act reporting entry into this Agreement. The Schedule&nbsp;13D/A shall be consistent
with the terms of this Agreement. The Investor shall provide the Company a reasonable opportunity to review and comment on the Schedule&nbsp;13D/A
prior to the filing of the Schedule&nbsp;13D/A with the SEC and shall consider in good faith any comments of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Term;
Termination</U></B></FONT>. The term of this Agreement shall commence on the Effective Date and shall continue until the date that is
the earlier of (a)&nbsp;thirty (30) days prior to the notice deadline under the Bylaws for the submission of shareholder director nominations
for the Company&rsquo;s 2026 annual meeting of shareholders and (b)&nbsp;one hundred (100) days prior to the first anniversary of the
2025 Annual Meeting (such earlier date, the &ldquo;<B>Termination Date</B>&rdquo;); <U>provided</U>, <U>however</U>, that (i)&nbsp;the
Investor may earlier terminate this Agreement if the Company commits a material breach of its obligations under this Agreement that (if
capable of being cured) is not cured within fifteen (15)&nbsp;days after receipt by the Company from the Investor of written notice specifying
the material breach, or, if impossible to cure within fifteen (15)&nbsp;days, that the Company has not taken any substantive action to
cure within such fifteen (15)&nbsp;day period, and (ii)&nbsp;the Company may earlier terminate this Agreement if the Investor commits
a material breach of this Agreement that (if capable of being cured) is not cured within fifteen (15)&nbsp;days after receipt by the Investor
from the Company of written notice specifying the material breach, or, if impossible to cure within fifteen (15)&nbsp;days, that the Investor
has not taken any substantive action to cure within such fifteen (15)&nbsp;day period. Notwithstanding the foregoing, the provisions of
<U>Section&nbsp;12</U> through <U>Section&nbsp;24</U> shall survive the termination of this Agreement. Termination of this Agreement shall
not relieve either Party from its responsibilities in respect of any breach of this Agreement prior to such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Expenses</U></B></FONT>.
Each Party shall bear its own expenses in connection with the negotiation, execution and effectuation of this Agreement and the transactions
contemplated hereby; <U>provided</U>, <U>however</U>, that the Company shall reimburse the Investor for its reasonable and well documented
out-of-pocket legal fees incurred by the Investor in connection with the negotiation, execution and effectuation of this Agreement and
the transactions contemplated hereby; <U>provided</U>, that such reimbursement and the timing thereof shall be in the manner agreed upon
between the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Governing
Law; Jurisdiction</U></B></FONT>. This Agreement is for the benefit of each of the Investor and the Company and is governed by the laws
of the State of Iowa without regard to any conflict of laws principles thereof. Any action brought in connection with this Agreement shall
be brought in the federal or state courts located in the State of Iowa. The Parties hereby (a)&nbsp;irrevocably submit to the exclusive
jurisdiction of such courts for the purpose of any such action or proceeding, (b)&nbsp;waive any objection to laying venue in any such
action or proceeding in such courts, (c)&nbsp;waive any objection that such courts are an inconvenient forum or do not have jurisdiction
over either Party hereto and (d)&nbsp;agree that service of process upon such Party in any such action shall be effective if notice is
given in accordance with <U>Section&nbsp;18</U> of this Agreement. Each Party agrees that a final judgment in any action brought in such
courts shall be conclusive and binding upon each Party and may be enforced in any other courts, the jurisdiction of which each Party is
or may be subject, by suit upon such judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Waiver
of Jury Trial</U></B></FONT>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO
REPRESENTATIVE OF ANY OTHER PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE
FOREGOING WAIVER IN THE EVENT OF A <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">LEGAL ACTION, (B)&nbsp;SUCH
PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D)&nbsp;SUCH PARTY HAS BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION&nbsp;15</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Specific
Performance</U></B></FONT>. Each Party acknowledges and agrees that irreparable injury to the other Party may occur in the event any of
the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached and that such injury
may not be adequately compensable by the remedies available at law (including, but not limited to, the payment of money damages). It is
accordingly agreed that each Party (the &ldquo;<B>Moving Party</B>&rdquo;) shall be entitled to seek specific enforcement of, and injunctive
or other equitable relief as a remedy for any such breach or to prevent any violation or threatened violation of, the terms hereof, and
the other Party will not take action, directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that
any other remedy or relief is available at law or in equity. The Parties further agree to waive any requirement for the security or posting
of any bond in connection with any such relief. The remedies available pursuant to this <U>Section&nbsp;16</U> shall not be deemed to
be the exclusive remedies for a breach of this Agreement but shall be in addition to all other remedies available at law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Certain
Definitions</U></B></FONT>. As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Affiliate</B>&rdquo;
shall mean any &ldquo;<B>Affiliate</B>&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, and, for the
avoidance of doubt, including, but not limited to, persons who become Affiliates prior to the Termination Date; <U>provided</U>, <U>however</U>,
that, for purposes of this Agreement, the Investor shall not be deemed an Affiliate of the Company and the Company shall not be deemed
an Affiliate of the Investor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Articles
of Incorporation</B>&rdquo; shall mean the Second Amended and Restated Articles of Incorporation of the Company, dated October&nbsp;10,
2008, as amended by the Articles of Amendment, dated May&nbsp;9, 2011, the Second Articles of Amendment, dated May&nbsp;14, 2014, and
the Third Articles of Amendment, dated May&nbsp;4, 2022, and as may be further amended, corrected, or amended and restated from time to
time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Associate</B>&rdquo;
shall mean any &ldquo;<B>Associate</B>&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, and, for the
avoidance of doubt, including, but not limited to, persons who become Associates prior to the Termination Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>beneficial
owner</B>,&rdquo; &ldquo;<B>beneficial ownership</B>&rdquo; and &ldquo;<B>beneficially own</B>&rdquo; shall have the same meanings as
set forth in Rule&nbsp;13d-3 promulgated by the SEC under the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>business
day</B>&rdquo; shall mean any day other than a Saturday, Sunday or day on which the commercial banks in the State of New York are authorized
or obligated to be closed by applicable law; <U>provided</U>, <U>however</U>, that banks shall not be deemed to be authorized or obligated
to be closed due to a &ldquo;shelter in place,&rdquo; &ldquo;non-essential employee&rdquo; or similar closure of physical branch locations
at the direction of any Governmental Authority if such banks&rsquo; electronic funds transfer systems (including, but not limited to,
for wire transfers) are open for use by customers on such day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Bylaws</B>&rdquo;
shall mean the Fifth Amended and Restated Bylaws of the Company, adopted as of November&nbsp;14, 2022, as may be further amended, corrected,
or amended and restated from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
&ldquo;<B>Change of Control</B>&rdquo; transaction shall be deemed to have taken place if (i)&nbsp;any person is or becomes a beneficial
owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the equity interests and voting
power of the Company&rsquo;s then-outstanding equity securities or (ii)&nbsp;the Company enters into a stock-for-stock transaction whereby
immediately after the consummation of the transaction the Company&rsquo;s shareholders retain less than fifty percent (50%) of the equity
interests and voting power of the surviving entity&rsquo;s then-outstanding equity securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Extraordinary
Transaction</B>&rdquo; shall mean any equity tender offer, equity exchange offer, merger, acquisition, joint venture, business combination,
financing, restructuring, recapitalization, reorganization, disposition, distribution, or other transaction with a Third Party that, in
each case, would require the approval of such action or event by shareholders of the Company and would result in a Change of Control of
the Company, liquidation, dissolution or other extraordinary transaction involving a majority of its equity securities or a majority of
its assets, and, for the avoidance of doubt, including, but not limited to, any such transaction with a Third Party that is submitted
for a vote of the Company&rsquo;s shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Governmental
Authority</B>&rdquo; shall mean any federal, state, local, municipal, or foreign government and any political subdivision thereof, any
authority, bureau, commission, department, board, official, or other instrumentality of such government or political subdivision, any
self-regulatory organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules,
regulations or orders of such organization or authority have the force of law), including, but not limited to, the SEC and its staff,
and any court of competent jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Minimum
Ownership Threshold</B>&rdquo; shall mean beneficial ownership of Common Stock representing at least 2.5% of the Company&rsquo;s then
issued and outstanding Common Stock (subject to adjustment for stock splits, reclassifications, combinations and similar events);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>person</B>&rdquo;
or &ldquo;<B>persons</B>&rdquo; shall mean any individual, corporation (including, but not limited to, not-for-profit), general or limited
partnership, limited liability company, joint venture, estate, trust, association, organization or other entity of any kind, structure
or nature;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Representative</B>&rdquo;
shall mean (i)&nbsp;a person&rsquo;s Affiliates and Associates and (ii)&nbsp;its and their respective directors, officers, employees,
partners, members, managers, consultants or other advisors, agents and other representatives; <U>provided</U>, that when used with respect
to the Company, &ldquo;<B>Representatives</B>&rdquo; shall not include any non-executive employees;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>SEC</B>&rdquo;
shall mean the U.S. Securities and Exchange Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Third
Party</B>&rdquo; shall mean any person that is not (i)&nbsp;a party to this Agreement, (ii)&nbsp;a member of the Board, (iii)&nbsp;an
officer of the Company or (iv)&nbsp;an Affiliate of either Party; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Voting
Securities</B>&rdquo; means the Common Stock and any other securities of the Company entitled to vote in the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Notices</U></B></FONT>.
All notices, requests, consents, claims, demands, waivers, and other communications hereunder shall be in writing and shall be deemed
to have been given: (a)&nbsp;when delivered by hand (with written confirmation of receipt); (b)&nbsp;when received by the addressee if
sent by a nationally recognized overnight courier (receipt requested); (c)&nbsp;on the date sent by email (with confirmation of transmission)
if sent during normal business hours, and on the next business day if sent after normal business hours; or (d)&nbsp;on the third day after
the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective
Party at the addresses set forth in this <U>Section&nbsp;18</U> (or to such other address that may be designated by a Party from time
to time in accordance with this <U>Section&nbsp;18</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">If to the Company, to its address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">Green Plains Inc.<BR>
1811 Aksarben Drive<BR>
Omaha, Nebraska 68106<BR>
Attention: Michelle Mapes<BR>
Email: michelle.mapes@gpreinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left"><I>with a copy (which shall not constitute
notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">Vinson &amp; Elkins L.L.P.<BR>
1114 Avenue of the Americas, 32nd Floor<BR>
New York, New York 10036<BR>
Attention:&#9;Lawrence S. Elbaum<BR>
C. Patrick Gadson<BR>
Email:&#9;lelbaum@velaw.com<BR>
pgadson@velaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">If to the Investor, to the address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">Ancora Holdings Group, LLC<BR>
6060 Parkland Boulevard, Suite 200<BR>
Cleveland, Ohio 44124<BR>
Attention:&#9;Jim Chadwick<BR>
Email:&#9;jchadwick@ancora.net</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left"><I>with a copy (which shall not constitute
notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: left">Olshan Frome Wolosky LLP<BR>
1325 Avenue of the Americas<BR>
New York, New York 10019<BR>
Attention:&#9;Andrew M. Freedman<BR>
Email:&#9;afreedman@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Entire
Agreement</U></B></FONT>. This Agreement, except as expressly provided otherwise in <U>Section 13</U> hereof, constitutes the sole and
entire agreement of the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings,
agreements, representations, and warranties, both written and oral, with respect to such subject matter. This Agreement may only be amended,
modified or supplemented by an agreement in writing signed by each Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Severability</U></B></FONT>.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Counterparts</U></B></FONT>.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed
to have the same legal effect as delivery of an original signed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Assignment</U></B></FONT>.
No Party may assign any of its rights or delegate any of its obligations hereunder without the prior written consent of the other Party;
<U>provided</U>, that either Party may assign any of its rights and delegate any of its obligations hereunder to any person or entity
that acquires substantially all of that Party&rsquo;s assets, whether by stock sale, merger, asset sale or otherwise. Any purported assignment
or delegation in violation of this <U>Section&nbsp;22</U> shall be null and void. No assignment or delegation shall relieve the assigning
or delegating Party of any of its obligations hereunder. This Agreement is for the sole benefit of the Parties and their respective successors
and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person or entity any legal
or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Waivers</U></B></FONT>.
No waiver by either Party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the
Party so waiving. No waiver by either Party shall operate or be construed as a waiver in respect of any failure, breach, or default not
expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver.
No failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Agreement shall operate or be
construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any
other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Interpretation</U></B></FONT>.
Each Party acknowledges that it has been represented by counsel of its choice throughout all negotiations that have preceded the execution
of this Agreement and that it has executed the same with the advice of said counsel. Each Party and its respective counsel cooperated
and participated in the drafting and preparation of this Agreement and the documents referred to herein, and any and all drafts relating
thereto exchanged among the parties shall be deemed the work product of the Parties and may not be construed against either Party by reason
of its drafting or preparation. Accordingly, any rule of law or any legal decision that would require interpretation of any ambiguities
in this Agreement against either Party that drafted or prepared it is of no application and is expressly waived by each Party hereto,
and any controversy over interpretations of this Agreement shall be decided without regard to events of drafting or preparation. The headings
set forth in this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the
meaning or interpretation of this Agreement or any term or provision of this Agreement. In this Agreement, unless a clear contrary intention
appears, (a)&nbsp;the word &ldquo;including&rdquo; (in its various forms) means &ldquo;including, but not limited to;&rdquo; (b)&nbsp;the
words &ldquo;hereunder,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereto&rdquo; and words of similar import are references in this Agreement
as a whole and not to any particular provision of this Agreement; (c)&nbsp;the word &ldquo;or&rdquo; is not exclusive; (d)&nbsp;references
to &ldquo;Sections&rdquo; in this Agreement are references to Sections of this Agreement unless otherwise indicated; and (e)&nbsp;whenever
the context requires, the masculine gender shall include the feminine and neuter genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(Remainder of Page Intentionally Left Blank)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement to be effective as of the Effective Date.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>The Company</U>:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GREEN PLAINS INC.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; border-bottom: Black 0.5pt solid">/s/ Jim Anderson</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Name:</TD>
    <TD STYLE="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Jim Anderson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Chairman of the Board</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><U></U></B></P>

<!-- Field: Page; Sequence: 18; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-style: italic; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Signature Page to Cooperation Agreement</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>The Investor:</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ANCORA HOLDINGS GROUP, LLC</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Name:</TD>
    <TD STYLE="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Fredrick DiSanto</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Chairman and Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U></U></B></P>

<!-- Field: Page; Sequence: 19; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-style: italic; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Signature Page to Cooperation Agreement</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>Exhibit A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[Form of Irrevocable Resignation]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 20; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>Exhibit B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[Press Release]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Options: NewSection Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ex992to13da506470035_041525.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 99.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B><U>JOINT FILING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; background-color: white">In
accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint
filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of
Common Stock, par value $0.001 per share, of Green Plains Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Dated: April 15, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">Ancora Alternatives LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Merlin, LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">ANCORA MERLIN INSTITUTIONAL, LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Catalyst, LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Catalyst Institutional, LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Bellator Fund, LP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Impact Fund LP - Series Q</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Impact Fund LP - Series S</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor and General Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Impact Fund SPC Ltd. - Segregated Portfolio H</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Ancora Alternatives LLC, Investment Advisor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">ANCORA FAMILY WEALTH ADVISORS, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member of Inverness Holdings LLC, Sole Member</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Inverness Holdings LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO of Ancora Holdings Group, LLC, Sole Member</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Ancora Holdings Group, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto, Chair and CEO</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">DiSanto Frederick D.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 1.45pt; padding-left: 1.45pt">By:</TD>
    <TD STYLE="width: 45%; padding-right: 1.45pt; padding-left: 1.45pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Fredrick DiSanto</P></TD>
    <TD STYLE="width: 50%; padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Fredrick DiSanto</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt">Date:</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.45pt; padding-left: 1.45pt">4/15/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
